The Daily Hit: June 8, 2021

It’s time for your Daily Hit of cannabis financial news for June 8, 2021.

On The Site

Top Magazines

It is truly a labor of love to put out a regular print publication. A combination of writers, artists, printers, and distributors. Not to mention the trying to sell the advertising to pay for all of this. While most of us consume our media on our phones, there is something deeply satisfying when reading a story on paper accompanied by beautiful photographs. The pictures on our phones just don’t have the same impact. Plus, who doesn’t love to see themselves or their company featured in a print publication? So with that said, we put together a list of the top cannabis industry print publications. They are listed in alphabetical order.

Tilray

Tilray, Inc. (NASDAQ: TLRY) is launching a new medical marijuana product called Symbios. The company said that the new brand was developed to provide a broader product at a better price point. Potency will range from 15%-18% and all flower is grown in the same Greenhouse as Aphria-branded flower. Current strains include Nordle, Treasure Island, Sour Kush, Jack Herer, Exodus Cheese, and Grower’s Blend (milled flower).

Mydecine

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) reports that its R&D team has discovered over 40 compounds with pharmacological potential in mushrooms. Mydecine said that it has screened over 25 mushroom species, including various varieties of p. cubensis, and has selected and analyzed over 40 unique compounds found throughout the various species. Of these compounds, a large majority appear to have never been reported before and could be vital to the critical effects of naturally-sourced mushrooms on human health and wellbeing as well as synergistic effects with pure psilocybin.

Brightfield

The cannabis industry’s proof was in 2020’s revenue, but Brightfield’s newest report shows consumer behavior to match exactly what the cannabis industry already knew: people consumed more cannabis during the pandemic than they were before. 

Marley Natural

It is surely a move that Bob Marley never would have dreamed could happen. A dispensary bearing his name, legally selling his beloved herb in his home country of Jamaica. The Marley family and Docklight Brands announced that the Marley Natural will open a new, first-of-its-kind Marley Natural dispensary located at Bob’s former home and recording studio, which is currently the Bob Marley Museum, in Kingston, Jamaica. Privately owned Docklight Brands, Inc. holds the exclusive global rights to Bob Marley cannabinoid products. Docklight was founded by Privateer Holdings.

In Other News

Field Trip Health Ltd. (OTCQX: FTRPF) has applied to list its common shares on the NASDAQ Stock Market. “Psychedelics stand poised to disrupt modern psychiatry, and the NASDAQ is where world class companies whose ambition is disruption list to reach a global audience of investors,” said Ronan Levy , Field Trip’s Executive Chairman. “By applying to list on the NASDAQ, we are declaring to the world that Field Trip is such a world class company.”

HERBL, California’s largest cannabis supply chain solutions company, today announced its acquisition of Blackbird, a premier cannabis distributor and direct-to-consumer software solutions company based in Nevada. The transaction allows HERBL to leverage Blackbird’s ecosystem of national retail and logistics insights to enter the Nevada market and create the most comprehensive supply chain platform in the industry. The acquisition positions HERBL as the leading multi-state supply chain company that serves 98% of California’s and Nevada’s cannabis retailers. BlackbirdGo, Blackbird’s proprietary e-commerce platform, will be seamlessly integrated into HERBL’s retail services offering, providing a new sales channel that connects retailers and consumers to HERBL’s portfolio of best-selling brands.